Monday Natus Medical Inc (BABY) $BABY opened at 24.13 hitting the high price of 24.78 and a day low of 24.08 with a total volume of 251,710. BABY had a previous close of 24.34 and has been seeing an average volume of 375,426.
Overall Average: 8% Sell
Recent stock forum discussions about BABY http://investorshangout.com/search?q=BABY&...mp;yt0=Go!
Natus to Present at UBS Global Healthcare Conference
Business Wire - Mon May 05, 6:30AM CDT
Natus Medical Incorporated (NASDAQ: BABY) today announced that Jonathan Kennedy, Sr. Vice President and Chief Financial Officer, will present at the UBS Global Healthcare Conference in New York City. Mr. Kennedy is scheduled to present at 11:30 a.m. Eastern Time (8:30 a.m. PT) on Monday, May 19, 2014. (full story)
Teleflex 1Q Earnings Rise, Beat Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 30, 2:03PM CDT
For 2014, Teleflex continues to expect revenue growth between 6.0 and 8.0% versus 2013. (full story)
Haemonetics Slips on Q4 Earnings and Revs Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 30, 1:50PM CDT
Haemonetics Corporation (HAE) reports disappointing fourth-quarter and fiscal 2014 financial results. (full story)
Luminex 1Q Earnings Rise 50%, Beat Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 29, 1:13PM CDT
For 2014, Luminex reiterated its revenue guidance in the range of $225 to $240 million, reflecting an increase of 5 to 12% over 2013. (full story)
Abaxis' Fiscal Q4 Earnings, Revs Disappoint Again - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 29, 10:50AM CDT
Abaxis, Inc. (ABAX) delivers disappointing fourth-quarter and fiscal 2014 financial results (full story)
RadNet (RDNT) Catches Eye: Stock Rises 6.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 29, 8:46AM CDT
RadNet (RDNT) was a big mover last session, with shares rising over 6% on the day. (full story)
AmSurg Lags Q1 Earnings & Revs, Trims 2014 EPS View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 28, 8:40AM CDT
AmSurg Corp. (AMSG) delivers disappointing first-quarter 2014 financial results. (full story)
Align Technology Beats on Top & Bottom, Guides High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 28, 8:11AM CDT
Align Technology Inc. (ALGN) delivers better-than-expected first-quarter 2014 results. (full story)
3 Stocks Rising on Big Volume
at The Street - Thu Apr 24, 8:18AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility. (full story)
Natus Medical posts higher net income of USD6.3m for Q1 2014
M2 - Thu Apr 24, 5:55AM CDT
Healthcare company Natus Medical (NasdaqGS:BABY) disclosed on Wednesday its net income of USD6.3m (USD0.19 per diluted share) for the three months ended 31 March 2014. (full story)
Why Natus Medical (BABY) Stock Is Soaring Today
at The Street - Wed Apr 23, 12:44PM CDT
Shares of Natus Medical (BABY) are surging, up 6.60% to $26.00, after the healthcare products company reported financial results for the 2014 first quarter. (full story)
Natus, Skechers Rally, But Techs Drag Indexes Lower
at Investor's Business Daily - Wed Apr 23, 11:07AM CDT
The major averages were trading near their intraday lows in midday trade as tech stocks sold off hard. Software-makers and biotechs weighed on the Nasdaq, which was down 0.5%. The Dow and S&P 500 were each off 0.1%. Volume was tracking lower across... (full story)
Natus Medical Announces First Quarter 2014 Financial Results
Business Wire - Wed Apr 23, 6:31AM CDT
--Reports non-GAAP gross profit margin of 59.5% (full story)
Uptrend Call Working As Natus Medical Stock Rises 60.6% (BABY)
Comtex SmarTrend(R) - Fri Apr 11, 4:48PM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on October 2nd, 2013 at $14.42. In approximately 6 months, Natus Medical has returned 60.61% as of today's recent price of $23.16. (full story)
U.S. Market for Female and Neonatal Diagnostic Devices - 10 Year Forecasts for the $1 Billion Industry
M2 - Thu Apr 10, 8:38AM CDT
Research and Markets (http://www.researchandmarkets.com/research/75j8xj/u_s_market_for) has announced the addition of the "U.S. Market for Female and Neonatal Diagnostic Devices" report to their offering. In 2012, the U.S. market for female and neonatal diagnostic devices was valued at over $1 billion. This report covers devices used for bone densitometry, breast biopsy, breast imaging, OB/GYN ultrasound imaging, fetal and neonatal monitoring, infant warmers and incubators. The majority of these market segments will see stable growth throughout the forecast period of this report, despite slow national economic growth. In 2012, the largest segment of this market was represented by breast imaging. This is primarily due to the large number of screening procedures performed with these devices, which add to the demand of the device. Moreover, the ASP of these devices is high in comparison to the devices from other markets discussed in this report. This report pertains to a forecast period of 10 years (2009 - 2019) for the U.S. market. Main Segments Included: - U.S. Female and Neonatal Diagnostic Device Market - Bone Densitometry Market - Breast Biopsy Device Market - Breast Imaging Market - Obstetrics and Genecology Ultrasound Market - Fetal and Neonatal Monitoring Market - Infant Warmer and Incubator Market Key Topics Covered: - U.S. Markets For Female And Neonatal Diagnostic Devices - Full Suite Executive Summary - Research Methodology - U.S. Female And Neonatal Diagnostic Device Market Overview - Bone Densitometry Market - Breast Biopsy Device Market - Breast Imaging Market - Obstetrics And Gynecology Ultrasound Market - Fetal And Neonatal Monitoring Device Market - Infant Warmer And Incubator Market - Appendix I: Gynecological Chair Market - Appendix II: Breast Tomosynthesis Companies Mentioned - C. R. Bard - CareFusion - Cooper Surgical - Devicor Medical Products - Dilon Technologies - Draeger Medical - Fujifilm Medical Systems - GE Healthcare - Hitachi-Aloka Medical Systems America - Hollister - Intact Medical - International Biomedical - Lone Oak Medical Technologies - Machnet B.V. - Natus Medical - Naviscan - Osteometer MediTech - Philips Healthcare - Philips Medical Systems - SRS Medical - Samsung Medison - Scion Medical Technologies - Siemens Healthcare - Smith & Nephew - Smiths Medical - Spacelabs Healthcare - Stryker - Sunlight Medical (Wallach Surgical) - Supersonic - Welch Allyn For more information visit http://www.researchandmarkets.com/research/75...market_for (full story)
Natus Medical to Hold 2014 First Quarter Financial Results Conference Call on April 23rd
Business Wire - Wed Apr 09, 6:30AM CDT
Natus Medical Incorporated (NASDAQ: BABY) today announced that the Company will release its 2014 first quarter financial results before the market opens on Wednesday, April 23. Natus management will host an investment-community conference call the same day beginning at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) to discuss those results and to answer questions. (full story)
Electrodes for Medical Devices - Global Strategic Business Report 2014
M2 - Tue Apr 08, 8:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/vg6kh7/electrodes_for) has announced the addition of the "Electrodes for Medical Devices - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Electrodes for Medical Devices in US$ Thousand by the following Product Segments: Blood Gas Electrodes, Defibrillator Electrodes, ECG Electrodes, EEG/EMG/ENG Electrodes, Electrosurgical Electrodes, Ion-selective Electrodes, pH Electrodes, Pacemaker Electrodes, and TENS Electrodes. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 111 companies including many key and niche players such as: - 3M Company - Ambu A/S - CONMED Corporation - Covidien - C.R Bard, Inc. - Katecho, Inc. - Leonhard Lang GmbH - Natus Medical Incorporated - Nikomed USA, Inc. - Philips Healthcare - Prosurg, Inc. - Rhythmlink International, LLC - Utah Medical Products Inc. - ZOLL Medical Corporation Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. EXECUTIVE SUMMARY 1. OUTLOOK 2. MARKET DYNAMICS & TRENDS 3. PRODUCT OVERVIEW 4. PRODUCT INTRODUCTIONS/INNOVATIONS 5. RECENT INDUSTRY ACTIVITY 6. FOCUS ON SELECT PLAYERS 7. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. THE MIDDLE EAST 7. LATIN AMERICA IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 111 (including Divisions/Subsidiaries 125) - The United States (85) - Canada (4) - Japan (2) - Europe (31) - France (2) - Germany (
- The United Kingdom (5) - Italy (2) - Spain (1) - Rest of Europe (13) - Asia-Pacific (Excluding Japan) (2) - Latin America (1) For more information visit http://www.researchandmarkets.com/research/vg...trodes_for (full story)
Uptrend Call Working As Natus Medical Stock Rises 78.4% (BABY)
Comtex SmarTrend(R) - Fri Apr 04, 11:00AM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on October 2nd, 2013 at $14.42. In approximately 6 months, Natus Medical has returned 78.43% as of today's recent price of $25.73. (full story)
Shares of BABY Up 72.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Mar 28, 9:38AM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on October 2nd, 2013 at $14.42. In approximately 6 months, Natus Medical has returned 72.12% as of today's recent price of $24.82. (full story)
ABIOMED's Impella Trial Achieves Enrollment Target - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 24, 2:20PM CDT
On reaching the enrollment target, ABIOMED plans to submit the compiled data and seek FDA approval for a Continuous Access Protocol. (full story)
Overall Average: 8% Sell
Recent stock forum discussions about BABY http://investorshangout.com/search?q=BABY&...mp;yt0=Go!
Natus to Present at UBS Global Healthcare Conference
Business Wire - Mon May 05, 6:30AM CDT
Natus Medical Incorporated (NASDAQ: BABY) today announced that Jonathan Kennedy, Sr. Vice President and Chief Financial Officer, will present at the UBS Global Healthcare Conference in New York City. Mr. Kennedy is scheduled to present at 11:30 a.m. Eastern Time (8:30 a.m. PT) on Monday, May 19, 2014. (full story)
Teleflex 1Q Earnings Rise, Beat Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 30, 2:03PM CDT
For 2014, Teleflex continues to expect revenue growth between 6.0 and 8.0% versus 2013. (full story)
Haemonetics Slips on Q4 Earnings and Revs Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 30, 1:50PM CDT
Haemonetics Corporation (HAE) reports disappointing fourth-quarter and fiscal 2014 financial results. (full story)
Luminex 1Q Earnings Rise 50%, Beat Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 29, 1:13PM CDT
For 2014, Luminex reiterated its revenue guidance in the range of $225 to $240 million, reflecting an increase of 5 to 12% over 2013. (full story)
Abaxis' Fiscal Q4 Earnings, Revs Disappoint Again - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 29, 10:50AM CDT
Abaxis, Inc. (ABAX) delivers disappointing fourth-quarter and fiscal 2014 financial results (full story)
RadNet (RDNT) Catches Eye: Stock Rises 6.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 29, 8:46AM CDT
RadNet (RDNT) was a big mover last session, with shares rising over 6% on the day. (full story)
AmSurg Lags Q1 Earnings & Revs, Trims 2014 EPS View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 28, 8:40AM CDT
AmSurg Corp. (AMSG) delivers disappointing first-quarter 2014 financial results. (full story)
Align Technology Beats on Top & Bottom, Guides High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 28, 8:11AM CDT
Align Technology Inc. (ALGN) delivers better-than-expected first-quarter 2014 results. (full story)
3 Stocks Rising on Big Volume
at The Street - Thu Apr 24, 8:18AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility. (full story)
Natus Medical posts higher net income of USD6.3m for Q1 2014
M2 - Thu Apr 24, 5:55AM CDT
Healthcare company Natus Medical (NasdaqGS:BABY) disclosed on Wednesday its net income of USD6.3m (USD0.19 per diluted share) for the three months ended 31 March 2014. (full story)
Why Natus Medical (BABY) Stock Is Soaring Today
at The Street - Wed Apr 23, 12:44PM CDT
Shares of Natus Medical (BABY) are surging, up 6.60% to $26.00, after the healthcare products company reported financial results for the 2014 first quarter. (full story)
Natus, Skechers Rally, But Techs Drag Indexes Lower
at Investor's Business Daily - Wed Apr 23, 11:07AM CDT
The major averages were trading near their intraday lows in midday trade as tech stocks sold off hard. Software-makers and biotechs weighed on the Nasdaq, which was down 0.5%. The Dow and S&P 500 were each off 0.1%. Volume was tracking lower across... (full story)
Natus Medical Announces First Quarter 2014 Financial Results
Business Wire - Wed Apr 23, 6:31AM CDT
--Reports non-GAAP gross profit margin of 59.5% (full story)
Uptrend Call Working As Natus Medical Stock Rises 60.6% (BABY)
Comtex SmarTrend(R) - Fri Apr 11, 4:48PM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on October 2nd, 2013 at $14.42. In approximately 6 months, Natus Medical has returned 60.61% as of today's recent price of $23.16. (full story)
U.S. Market for Female and Neonatal Diagnostic Devices - 10 Year Forecasts for the $1 Billion Industry
M2 - Thu Apr 10, 8:38AM CDT
Research and Markets (http://www.researchandmarkets.com/research/75j8xj/u_s_market_for) has announced the addition of the "U.S. Market for Female and Neonatal Diagnostic Devices" report to their offering. In 2012, the U.S. market for female and neonatal diagnostic devices was valued at over $1 billion. This report covers devices used for bone densitometry, breast biopsy, breast imaging, OB/GYN ultrasound imaging, fetal and neonatal monitoring, infant warmers and incubators. The majority of these market segments will see stable growth throughout the forecast period of this report, despite slow national economic growth. In 2012, the largest segment of this market was represented by breast imaging. This is primarily due to the large number of screening procedures performed with these devices, which add to the demand of the device. Moreover, the ASP of these devices is high in comparison to the devices from other markets discussed in this report. This report pertains to a forecast period of 10 years (2009 - 2019) for the U.S. market. Main Segments Included: - U.S. Female and Neonatal Diagnostic Device Market - Bone Densitometry Market - Breast Biopsy Device Market - Breast Imaging Market - Obstetrics and Genecology Ultrasound Market - Fetal and Neonatal Monitoring Market - Infant Warmer and Incubator Market Key Topics Covered: - U.S. Markets For Female And Neonatal Diagnostic Devices - Full Suite Executive Summary - Research Methodology - U.S. Female And Neonatal Diagnostic Device Market Overview - Bone Densitometry Market - Breast Biopsy Device Market - Breast Imaging Market - Obstetrics And Gynecology Ultrasound Market - Fetal And Neonatal Monitoring Device Market - Infant Warmer And Incubator Market - Appendix I: Gynecological Chair Market - Appendix II: Breast Tomosynthesis Companies Mentioned - C. R. Bard - CareFusion - Cooper Surgical - Devicor Medical Products - Dilon Technologies - Draeger Medical - Fujifilm Medical Systems - GE Healthcare - Hitachi-Aloka Medical Systems America - Hollister - Intact Medical - International Biomedical - Lone Oak Medical Technologies - Machnet B.V. - Natus Medical - Naviscan - Osteometer MediTech - Philips Healthcare - Philips Medical Systems - SRS Medical - Samsung Medison - Scion Medical Technologies - Siemens Healthcare - Smith & Nephew - Smiths Medical - Spacelabs Healthcare - Stryker - Sunlight Medical (Wallach Surgical) - Supersonic - Welch Allyn For more information visit http://www.researchandmarkets.com/research/75...market_for (full story)
Natus Medical to Hold 2014 First Quarter Financial Results Conference Call on April 23rd
Business Wire - Wed Apr 09, 6:30AM CDT
Natus Medical Incorporated (NASDAQ: BABY) today announced that the Company will release its 2014 first quarter financial results before the market opens on Wednesday, April 23. Natus management will host an investment-community conference call the same day beginning at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) to discuss those results and to answer questions. (full story)
Electrodes for Medical Devices - Global Strategic Business Report 2014
M2 - Tue Apr 08, 8:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/vg6kh7/electrodes_for) has announced the addition of the "Electrodes for Medical Devices - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Electrodes for Medical Devices in US$ Thousand by the following Product Segments: Blood Gas Electrodes, Defibrillator Electrodes, ECG Electrodes, EEG/EMG/ENG Electrodes, Electrosurgical Electrodes, Ion-selective Electrodes, pH Electrodes, Pacemaker Electrodes, and TENS Electrodes. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 111 companies including many key and niche players such as: - 3M Company - Ambu A/S - CONMED Corporation - Covidien - C.R Bard, Inc. - Katecho, Inc. - Leonhard Lang GmbH - Natus Medical Incorporated - Nikomed USA, Inc. - Philips Healthcare - Prosurg, Inc. - Rhythmlink International, LLC - Utah Medical Products Inc. - ZOLL Medical Corporation Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. EXECUTIVE SUMMARY 1. OUTLOOK 2. MARKET DYNAMICS & TRENDS 3. PRODUCT OVERVIEW 4. PRODUCT INTRODUCTIONS/INNOVATIONS 5. RECENT INDUSTRY ACTIVITY 6. FOCUS ON SELECT PLAYERS 7. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. THE MIDDLE EAST 7. LATIN AMERICA IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 111 (including Divisions/Subsidiaries 125) - The United States (85) - Canada (4) - Japan (2) - Europe (31) - France (2) - Germany (
- The United Kingdom (5) - Italy (2) - Spain (1) - Rest of Europe (13) - Asia-Pacific (Excluding Japan) (2) - Latin America (1) For more information visit http://www.researchandmarkets.com/research/vg...trodes_for (full story) Uptrend Call Working As Natus Medical Stock Rises 78.4% (BABY)
Comtex SmarTrend(R) - Fri Apr 04, 11:00AM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on October 2nd, 2013 at $14.42. In approximately 6 months, Natus Medical has returned 78.43% as of today's recent price of $25.73. (full story)
Shares of BABY Up 72.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Mar 28, 9:38AM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on October 2nd, 2013 at $14.42. In approximately 6 months, Natus Medical has returned 72.12% as of today's recent price of $24.82. (full story)
ABIOMED's Impella Trial Achieves Enrollment Target - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 24, 2:20PM CDT
On reaching the enrollment target, ABIOMED plans to submit the compiled data and seek FDA approval for a Continuous Access Protocol. (full story)
